WENDY FOSTER-CLARKE: Open Payments
NPI 1992487425 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 67 payments from 31 companies in 2025. Trend: 2023 $332 · 2024 $878 · 2025 $1,520
Food & beverage: $1,421Education: $99
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $208 |
| TerSera Therapeutics LLC | 3 | $107 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| Janssen Biotech, Inc. | 5 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Stemline Therapeutics Inc. | 3 | $71 |
| Pharmacosmos Therapeutics Inc. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| BeOne Medicines USA, Inc. | 3 | $62 |
| Incyte Corporation | 3 | $62 |
Products named: KEYTRUDA, Zoladex, FOTIVDA, Orserdu, MONOFERRIC, JAKAFI, ENHERTU, TEVIMBRA.
Industry payments across AL — which companies pay providers there.
